Impact of Admission Blood Glucose on Outcomes of Nondiabetic Patients With Acute ST-Elevation Myocardial Infarction (from the German Acute Coronary Syndromes [ACOS] Registry)

American Journal of Cardiology

Volumn 103, Issue 5, 2009, Pages 583-587

  Naber, Christoph K ^a   Mehta, Rajendra H ^b   Jünger, Claus ^c   Zeymer, Uwe ^c,d   Wienbergen, Harm ^d   Sabin, Georg V ^a   Erbel, Raimund ^e   Senges, Jochen ^c   Gitt, Anselm ^d  

^a ELISABETH KRANKENHAUS ESSEN   (Germany)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c Institut fur Herzinfarktforschung   (Germany)

^d KLINIKUM LUDWIGSHAFEN   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE REGISTRY; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION;

AGED; BLOOD GLUCOSE; ELECTROCARDIOGRAPHY; FEMALE; FLUID THERAPY; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RECURRENCE; STROKE; SURVIVAL RATE;

EID: 60549116388     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.11.005     Document Type: Article

References (20)

1. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycemia and increased risk after myocardial infarction in patients without diabetes: a systematic overview. Lancet 355 (2000) 773-778
2. Kosiborod M., Rathore S.S., Inzucchi S.E., Masoudi F.A., Wang Y., Havranek E.P., and Krumholz H.M. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
3. Bhadriraju S., Ray K.K., DeFranco A.C., Barber K., Bhadriraju P., Murphy S.A., Morrow D.A., McCabe C.H., Gibson C.M., Cannon C.P., and Braunwald E. Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial. Am J Cardiol 97 (2006) 1573-1577
4. Wienbergen H., Gitt A.K., Schiele R., Juenger C., Heer T., Vogel C., Gottwik M., Senges J., and ACOS Study Group. Different treatments and outcomes of consecutive patients with non-ST-elevation myocardial infarction depending on initial electrocardiographic changes (results of the Acute Coronary Syndromes [ACOS] Registry). Am J Cardiol 93 (2004) 1543-1546
5. Van de Werf F., Ardissino D., Betriu A., Cokkinos D.V., Falk E., Fox K.A., Julian D., Lengyel M., Neumann F.J., Ruzyllo W., et al., Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24 (2003) 28-66
6. Morrow D.A., Antmann E.M., Charlesworth A., Cairns R., Murphy S.A., de Lemos J.A., Giugliano R.P., McCabe C.H., and Braunwald E. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy. Circulation 102 (2000) 2031-2037
7. Goyal A., Mahaffey K.W., Garg J., Nicolau J.C., Hochmann J.S., Weaver W.D., Theroux P., Oliveira G.B.F., Todaro T.G., Mojcik C.F., Armstron P.W., and Granger C.B. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL Study. Eur Heart J 27 (2006) 1298-1297
8. Bartnik M., Ryden L., Ferrari R., Malmberg K., Pyorala K., Simoons M., Standl E., Soler-Soler J., Ohrvik J., and Euro Heart Survey Investigators. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 25 (2004) 1880-1890
9. Kosuge M., Kimura K., Kojima S., Sakamoto T., Matsui K., Ishihara M., Asada Y., Tei C., Miyazaki S., Sonoda M., et al., Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circ J 69 (2005) 375-379
10. Ishihara M., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Hata T., Nakama Y., Kijima Y., and Kagawa E. Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?. Eur Heart J 27 (2006) 2413-2419
11. Gresele P., Guglielmini G., De Angelis M., Ciferri S., Ciofetta M., Falcinelli E., Lalli C., Ciabattoni G., Davi G., and Bolli G.B. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 41 (2003) 1013-1020
12. Verma S., Wang C.H., Weisel R.D., Badiwala M.V., Li S.H., Fedak P.W., Li R.K., and Mickle D.A. Hyperglycemia potentiates the proatherogenic effects of C-reactive protein: reversal with rosiglitazone. J Mol Cell Cardiol 35 (2003) 417-419
13. Williams S.B., Goldfine A.B., Timimi F.K., Ting H.H., Roddy M.A., Simonson D.C., and Creager M.A. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97 (1998) 1695-1701
14. Timmer J.R., Ottervanger J.P., de Boer M.J., Dambrink J.H., Hoorntje J.C., Gosselink A.T., Suryapranata H., Zijlstra F., van't Hof A.W., and Zwolle Myocardial Infarction Study Group. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 45 (2005) 999-1002
15. Iwakura K., Ito H., Ikushima M., Kawano S., Okamura A., Asano K., Kuroda T., Tanaka K., Masuyama T., Hori M., and Fujii K. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41 (2003) 1-7
16. Pittas A.G., Siegel R.D., and Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med 164 (2004) 2005-2011
17. van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., and Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
18. Malmberg K., Ryden L., Efendic S., Herlitz J., Nicol P., Waldenstrom A., Wedel H., and Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
19. Malmberg K., Ryden L., Wedel H., Birkeland K., Bootsma A., Dickstein K., Efendic S., Fisher M., Hamsten A., Herlitz J., et al., DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661
20. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008) 2545-2559